@article{0c1e6fe227f1493ba1ff877cb804fe51,
title = "Advancing Women's Heart Health through Policy and Science: Highlights from the First National Policy and Science Summit on Women's Cardiovascular Health",
author = "{Scientific Advisory Council of WomenHeart: The National Coalition for Women with Heart Disease} and Wood, {Susan F.} and Mieres, {Jennifer H.} and Campbell, {Susan M.} and Wenger, {Nanette K.} and Hayes, {Sharonne N.}",
note = "Funding Information: Unrestricted funding for the Summit was received from Abbott Vascular, Inc., Boston Scientific Corporation (19765_0819), Eli Lilly and Company, Esperion, Gilead Sciences (16449), Genentech, Inc. (G-38655), Janssen Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation (NGC25122), Pfizer Inc., Sanofi and Regeneron. Funding Information: The authors acknowledge the contributions of WomenHeart's Scientific Advisory Council, WomenHeart Champions, who provided unique patient insights to the proceedings, and the following Summit partner organizations: American Association of Heart Failure Nurses, Jacobs Institute of Women's Health, StopAfib.org , The Familial Hypercholesterolemia Foundation, The Society for Women's Health Research, and The Preventive Cardiovascular Nurses Association. ",
year = "2016",
month = may,
day = "1",
doi = "10.1016/j.whi.2016.03.001",
language = "English (US)",
volume = "26",
pages = "251--255",
journal = "Women's Health Issues",
issn = "1049-3867",
publisher = "Elsevier USA",
number = "3",
}